Mepivacaine
From Wikipedia, the free encyclopedia
 |
|
|
Mepivacaine
|
|
| Systematic (IUPAC) name | |
| N-(2,6-dimethylphenyl)- 1-methyl-piperidine-2-carboxamide | |
| Identifiers | |
| CAS number | |
| ATC code | N01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C15H22N2O |
| Mol. mass | 246.348 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C, use w/ caution, may cause fetal bradycardia |
| Legal status | |
| Routes | ? |
Mepivacaine (pronounced /mɛˈpɪvəkeɪn/) is a local anesthetic of the amino amide type. Mepivacaine has a reasonably rapid onset (more rapid than that of procaine) and medium duration of action (shorter than that of procaine) and is marketed under various trade names including Carbocaine and Polocaine.
Mepivacaine became available in the United States in the 1960s.
Mepivacaine is used in local infiltration and regional anesthesia. It is chemically related to bupivacaine but pharmacologically related to lidocaine. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
[edit] External links
|
||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
